Cathepsin W is required for escape of influenza A virus from late endosomes

mBio

Volumn 6, Issue 3, 2015, Pages

  Edinger, Thomas O ^a   Pohl, Marie O ^a   Yángüez, Emilio ^a   Stertz, Silke ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN W;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CATALYSIS; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOSOME; HOST CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INTERNALIZATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RNA INTERFERENCE; UPREGULATION; VESICULOVIRUS; VIRION; VIRUS ENTRY; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TITRATION; ANIMAL; CELL LINE; GENE SILENCING; GENETIC COMPLEMENTATION; GENETIC SCREENING; HOST PATHOGEN INTERACTION; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; CATHEPSIN W; CELL LINE; ENDOSOMES; GENE KNOCKDOWN TECHNIQUES; GENETIC COMPLEMENTATION TEST; GENETIC TESTING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; VIRUS INTERNALIZATION;

EID: 84936971212     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00297-15     Document Type: Article

References (44)

1. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647-1689. In Knipe DM, Howley (ed), Fields virology, vol 2, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Baum LG, Paulson JC. 1990. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 40:35-38.
3. Matlin KS, Reggio H, Helenius A, Simons K. 1981. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91: 601-613. http://dx.doi.org/10.1083/jcb.91.3.601.
4. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jiménez V, Scholte F, García-Sastre A, Rottier PJ, de Haan CA. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7:e1001329. http://dx.doi.org/10.1371/ journal.ppat.1001329.
5. Sieczkarski SB, Whittaker GR. 2002. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol 76: 10455-10464. http://dx.doi.org/10.1128/JVI.76.20.10455-10464.2002.
6. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. 2003. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100: 9280-9285. http://dx.doi.org/10.1073/pnas.0832269100.
7. Mellman I. 1996. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12:575-625. http://dx.doi.org/10.1146/annurev.cellbio.12.1.575.
8. Maeda T, Ohnishi S. 1980. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett 122:283-287. http:// dx.doi.org/10.1016/0014-5793(80)80457-1.
9. Skehel JJ, WileyDC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569. http:// dx.doi.org/10.1146/annurev.biochem.69.1.531.
10. Cros JF, Palese P. 2003. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res 95: 3-12. http://dx.doi.org/10.1016/S0168-1702(03)00159-X.
11. Martin K, Helenius A. 1991. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65:232-244. http://dx.doi.org/ 10.1016/0962-8924(92)90130-F.
12. Edinger TO, Pohl MO, Stertz S. 2014. Entry of influenza A virus: host factors and antiviral targets. J Gen Virol 95:263-277. http://dx.doi.org/ 10.1099/vir.0.059477-0.
13. Ludwig S. 2009. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrob Chemother 64:1-4. http://dx.doi.org/10.1093/jac/dkp161.
14. Su WC, Chen YC, Tseng CH, Hsu PW, Tung KF, Jeng KS, Lai MM. 2013. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A 110:17516-17521. http://dx.doi.org/10.1073/ pnas.1312374110.
15. König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. 2010. Human host factors required for influenza virus replication. Nature 463:813-817. http://dx.doi.org/10.1038/ nature08699.
16. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Mäurer AP, Müller E, Wolff T, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822. http:// dx.doi.org/10.1038/nature08760.
17. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
18. Ward SE, Kim HS, Komurov K, Mendiratta S, Tsai PL, Schmolke M, Satterly N, Manicassamy B, Forst CV, Roth MG, García-Sastre A, Blazewska KM, McKenna CE, Fontoura BM, White MA. 2012. Host modulators of H1N1 cytopathogenicity. PLoS One 7:e39284. http:// dx.doi.org/10.1371/journal.pone.0039284.
19. Conus S, Simon HU. 2008. Cathepsins: key modulators of cell death and inflammatory responses. Biochem Pharmacol 76:1374-1382. http:// dx.doi.org/10.1016/j.bcp.2008.07.041.
20. Wex T, Levy B, Wex H, Brömme D. 1999. Human cathepsins F and W: a new subgroup of cathepsins. Biochem Biophys Res Commun 259: 401-407. http://dx.doi.org/10.1006/bbrc.1999.0700.
21. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. http://dx.doi.org/10.1126/ science.1110656.
22. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102:11876-11881. http://dx.doi.org/10.1073/pnas.0505577102.
23. Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol 86:6537-6545. http://dx.doi.org/ 10.1128/JVI.00094-12.
24. Diederich S, Sauerhering L, Weis M, Altmeppen H, Schaschke N, Reinheckel T, Erbar S, Maisner A. 2012. Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. J Virol 86:3736-3745. http:// dx.doi.org/10.1128/JVI.06628-11.
25. Wex T, Bühling F, Wex H, Günther D, Malfertheiner P, Weber E, Brömme D. 2001. Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J Immunol 167:2172-2178. http://dx.doi.org/10.4049/ jimmunol.167.4.2172.
26. Ondr JK, Pham CT. 2004. Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity. J Biol Chem 279:27525-27533. http://dx.doi.org/10.1074/jbc.M400304200.
27. Sun E, He J, Zhuang X. 2013. Dissecting the role of COPI complexes in influenza virus infection. J Virol 87:2673-2685. http://dx.doi.org/ 10.1128/JVI.02277-12.
28. Wex T, Levy B, Smeekens SP, Ansorge S, Desnick RJ, Bromme D. 1998. Genomic structure, chromosomal localization, and expression of human cathepsin W. Biochem Biophys Res Commun 248:255-261. http:// dx.doi.org/10.1006/bbrc.1998.8954.
29. Wex T, Bühling F, Wex H, Günther D, Malfertheiner P, Weber E, Brömme D. 2001. Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J Immunol 167:2172-2178. http://dx.doi.org/10.4049/ jimmunol.167.4.2172.
30. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151. http://dx.doi.org/10.1371/journal.ppat.1003151.
31. Rojek JM, Kunz S. 2008. Cell entry by human pathogenic arenaviruses. Cell Microbiol 10:828-835. http://dx.doi.org/10.1111/j.1462-5822.2007.01113.x.
32. Pager CT, Craft WW, Jr, Patch J, Dutch RE. 2006. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346:251-257. http://dx.doi.org/10.1016/ j.virol.2006.01.007.
33. Pager CT, Dutch RE. 2005. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 79:12714-12720. http:// dx.doi.org/10.1128/JVI.79.20.12714-12720.2005.
34. Stertz S, Shaw ML. 2011. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect 13: 516-525. http://dx.doi.org/10.1016/j.micinf.2011.01.012.
35. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC. 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431-439. http://dx.doi.org/10.1016/0092-8674(85)90157-6.
36. White JM, Wilson IA. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 105:2887-2896. http://dx.doi.org/10.1083/ jcb.105.6.2887.
37. He J, Sun E, Bujny MV, Kim D, Davidson MW, Zhuang X. 2013. Dual function of CD81 in influenza virus uncoating and budding. PLoS Pathog 9:e1003701. http://dx.doi.org/10.1371/journal.ppat.1003701.
38. Dolman NJ, Kilgore JA, Davidson MW. 2013. A review of reagents for fluorescence microscopy of cellular compartments and structures, part I: BacMam labeling and reagents for vesicular structures. Curr Protoc Cytom Chapter 12:Unit 12.30. http://dx.doi.org/10.1002/ 0471142956.cy1230s65.
39. Guha S, Padh H. 2008. Cathepsins: fundamental effectors of endolysosomal proteolysis. Indian J Biochem Biophys 45:-75-90.
40. Pillay CS, Elliott E, Dennison C. 2002. Endolysosomal proteolysis and its regulation. Biochem J 363:417-429. http://dx.doi.org/10.1042/0264-6021:3630417.
41. Nohinek B, Gerhard W, Schulze IT. 1985. Characterization of host cell binding variants of influenza virus by monoclonal antibodies. Virology 143:651-656. http://dx.doi.org/10.1016/0042-6822(85)90407-6.
42. Pohl MO, Edinger TO, Stertz S. 2014. Prolidase is required for early trafficking events during influenza A virus entry. J Virol 88:11271-11283. http://dx.doi.org/10.1128/JVI.00800-14.
43. Sakai T, Ohuchi M, Imai M, Mizuno T, Kawasaki K, Kuroda K, Yamashina S. 2006. Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells. J Virol 80:2013-2018. http:// dx.doi.org/10.1128/JVI.80.4.2013-2018.2006.
44. Banerjee I, Yamauchi Y, Helenius A, Horvath P. 2013. High-content analysis of sequential events during the early phase of influenza A virus infection. PLoS One 8:e68450. http://dx.doi.org/10.1371/ journal.pone.0068450.